Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: vicodin / accolate attending: addendum: antibiotics are to be completed on .pt has been on trach collar during day 8-12hrs and restes on vent overnoc cpcp 50% tv 350, 8peep, 8psv. *** his follow up appointment has been changed to at 3:30pm clinical center discharge medications: 1. acetaminophen 325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. 2. fluticasone 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day). 3. albuterol-ipratropium 103-18 mcg/actuation aerosol sig: four (4) puff inhalation q6h (every 6 hours) as needed. 4. albuterol 90 mcg/actuation aerosol sig: 2-4 puffs inhalation q4h (every 4 hours). 5. atorvastatin calcium 10 mg tablet sig: one (1) tablet po daily (daily). 6. potassium & sodium phosphates mg packet sig: one (1) packet po prn (as needed) as needed for phos less than 2.5. 7. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed. 8. docusate sodium 150 mg/15 ml liquid sig: one (1) po bid (2 times a day). 9. miconazole nitrate 2 % powder sig: one (1) appl topical prn (as needed). 10. nystatin 100,000 unit/g ointment sig: one (1) appl topical qid (4 times a day) as needed. 11. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed. 12. lansoprazole 30 mg susp,delayed release for recon sig: one (1) po daily (daily). 13. folic acid 1 mg tablet sig: one (1) tablet po daily (daily). 14. ferrous sulfate 300 mg/5 ml liquid sig: one (1) po daily (daily). 15. albuterol sulfate 0.083 % solution sig: one (1) inhalation q4-6h (every 4 to 6 hours) as needed. 16. heparin sodium (porcine) 5,000 unit/ml solution sig: one (1) injection tid (3 times a day). 17. metoprolol tartrate 25 mg tablet sig: one (1) tablet po bid (2 times a day). 18. ceftazidime-dextrose (iso-osm) 2 g/50 ml piggyback sig: one (1) intravenous q8h (every 8 hours) for 7 days: end date . 19. sertraline 50 mg tablet sig: 1 1/2 tabs tablet po at bedtime. 20. metoclopramide 5 mg/ml solution sig: one (1) injection q6h (every 6 hours). 21. lorazepam 0.5 mg iv q4h:prn 22. potassium chloride 40 meq / 100 ml sw iv prn k < 4.0 23. magnesium sulfate 3 gm / 250 ml ns iv prn mg=<1.6 24. magnesium sulfate 2 gm / 100 ml d5w iv prn 1.6 < mg <2.0 25. calcium gluconate 2 gm / 100 ml ns iv prn ica <1.12 26. morphine sulfate 2-4 mg iv q2h:prn 27. ciprofloxacin 400 mg/40 ml solution sig: one (1) intravenous twice a day for 7 days: end date . 28. insulin regular human subcutaneous discharge disposition: extended care facility: - discharge instructions: continue w/ pul rehab and physical rehab. currently trach collar during day and cpap 50% 350 peep 8, psv 8. followup instructions: call dr. office for any care related questions . you have a follow up appointment with dr. at 3:30pm in the clinical center 9 th floor. md procedure: venous catheterization, not elsewhere classified venous catheterization, not elsewhere classified venous catheterization, not elsewhere classified continuous invasive mechanical ventilation for 96 consecutive hours or more spinal tap incision of lung parenteral infusion of concentrated nutritional substances insertion of endotracheal tube enteral infusion of concentrated nutritional substances non-invasive mechanical ventilation percutaneous [endoscopic] gastrostomy [peg] other intubation of respiratory tract temporary tracheostomy other repair and plastic operations on trachea other repair and plastic operations on bronchus endoscopic excision or destruction of lesion or tissue of bronchus bronchial dilation removal of intraluminal foreign body from trachea and bronchus without incision infusion of vasopressor agent diagnoses: severe sepsis candidiasis of other urogenital sites acute and chronic respiratory failure pneumonia due to pseudomonas other specified septicemias septic shock candidiasis of lung diabetes mellitus without mention of complication, type i [juvenile type], not stated as uncontrolled other complications due to other internal prosthetic device, implant, and graft pneumonia due to streptococcus, unspecified supraglottitis unspecified, with obstruction atherosclerosis of native arteries of the extremities with ulceration ulcer of heel and midfoot other abnormal granulation tissue cryptococcosis cryptococcal meningitis vascular myelopathies 

Answer: The patient is high likely exposed to